4//SEC Filing
Melian Agustin 4
Accession 0000899243-22-025976
CIK 0001538927other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:24 PM ET
Size
7.6 KB
Accession
0000899243-22-025976
Insider Transaction Report
Form 4
Melian Agustin
EVP, Research & Development
Transactions
- Award
Stock Option (Right to Buy)
2022-07-11+118,000→ 118,000 totalExercise: $8.20Exp: 2032-07-10→ Common Stock (118,000 underlying) - Award
Common Stock
2022-07-11+79,000→ 79,000 total
Footnotes (2)
- [F1]These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
- [F2]25% of the shares subject to the stock option shall vest on July 11, 2023, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter.
Documents
Issuer
Forma Therapeutics Holdings, Inc.
CIK 0001538927
Entity typeother
Related Parties
1- filerCIK 0001818064
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:24 PM ET
- Size
- 7.6 KB